Literature DB >> 8511029

Role of adenosine triphosphate and adenosine in oxygen-induced pulmonary vasodilation in fetal lambs.

G G Konduri1, C T Gervasio, A A Theodorou.   

Abstract

We investigated the hypothesis that purine nucleotides, ATP and adenosine, mediate the pulmonary vasodilation that occurs at birth in response to an increase in arterial O2 pressure (PaO2). We studied 20 fetal lambs 1 to 3 d after placement of intravascular catheters and a flow transducer around left pulmonary artery. In 16 lambs, we investigated the effects of 1) an increase in fetal PaO2 on ATP levels in pulmonary circulation and 2) 8-phenyl-theophylline (8-PT) and cibacron blue, antagonists of receptors for adenosine and ATP, on pulmonary vasodilation caused by increased PaO2. In four other lambs, we investigated the specificity of 8-PT and cibacron blue for purine receptors by investigating their effects on pulmonary vasodilation caused by acetylcholine, bradykinin, and nitroprusside. The fetal PaO2 increased by 7 +/- 2 during administration of 100% O2 to the pregnant ewe, resulting in a 3-fold decrease in PVR and increase in pulmonary blood flow. Blood and plasma concentrations of ATP in fetal pulmonary artery and left atrium increased significantly during the increase in fetal PaO2. 8-PT and cibacron blue caused increases in baseline pulmonary and systemic vascular pressures and pulmonary vascular resistance and inhibited the pulmonary vasodilation caused by O2. 8-PT and cibacron blue did not alter the pulmonary vascular effects of acetylcholine, bradykinin, and nitroprusside. An increase in baseline pulmonary vascular resistance caused by infusion of U46619 (in four lambs) did not alter the pulmonary vasodilation caused by O2. In summary, O2-induced pulmonary vasodilation is accompanied by increased ATP levels in pulmonary circulation and is attenuated by antagonists of purine receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8511029     DOI: 10.1203/00006450-199305000-00022

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

Review 1.  Purinergic signaling in embryonic and stem cell development.

Authors:  Geoffrey Burnstock; Henning Ulrich
Journal:  Cell Mol Life Sci       Date:  2011-01-08       Impact factor: 9.261

2.  Purinergic receptor stimulation induces calcium oscillations and smooth muscle contraction in small pulmonary veins.

Authors:  Mauricio Henriquez; Marcelo Fonseca; Jose F Perez-Zoghbi
Journal:  J Physiol       Date:  2018-05-23       Impact factor: 5.182

3.  Late clinical manifestations of mitral valve disease and severe pulmonary hypertension in a patient diagnosed with premature closure of foramen ovale during fetal life.

Authors:  Yoichi Iwamoto; Akiko Tamai; Hidenori Kawasaki; Mio Taketazu; Hideaki Senzaki
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

Review 4.  The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy.

Authors:  S Lakshminrusimha; O D Saugstad
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

5.  Impaired voltage gated potassium channel responses in a fetal lamb model of persistent pulmonary hypertension of the newborn.

Authors:  Girija G Konduri; Ivane Bakhutashvili; Annie Eis; Kathryn M Gauthier
Journal:  Pediatr Res       Date:  2009-09       Impact factor: 3.756

Review 6.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

Review 7.  The Fetus Can Teach Us: Oxygen and the Pulmonary Vasculature.

Authors:  Payam Vali; Satyan Lakshminrusimha
Journal:  Children (Basel)       Date:  2017-08-03

8.  MRI shows limited mixing between systemic and pulmonary circulations in foetal transposition of the great arteries: a potential cause of in utero pulmonary vascular disease.

Authors:  Prashob Porayette; Joshua F P van Amerom; Shi-Joon Yoo; Edgar Jaeggi; Christopher K Macgowan; Mike Seed
Journal:  Cardiol Young       Date:  2014-06-16       Impact factor: 1.093

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.